Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit.
about
Mechanisms of hypoglycemia unawareness and implications in diabetic patientsRecommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileContinuous glucose monitoring: current use and future directionsAdherence decision making in the everyday lives of emerging adults with type 1 diabetes.Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes.Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial.Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetesSelf-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria.The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetesUse of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One YearHypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.Self-reported frequency, severity of, and awareness of hypoglycemia in type 2 diabetes patients in Turkey.Economic impact of hypoglycemia on healthcare in Spain.Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia.Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review.Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective.Moderate Recurrent Hypoglycemia Markedly Impairs Set-Shifting Ability in a Rodent Model: Cognitive and Neurochemical Effects.Hypoglycemia: from the laboratory to the clinic.Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.Impact of pH monitoring on laryngopharyngeal reflux treatment: improved compliance and symptom resolution.Diabetes management and daily functioning burden of non-severe hypoglycemia in Japanese people treated with insulin.Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?Banting memorial lecture 2013. A life in balance: wandering the pathways of control.Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project.Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada.Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice.
P2860
Q26799608-190586C8-FDAE-4DBF-97CC-CE79C5973A2FQ27687563-81A675F3-C14A-4932-9078-DA98E80B9D55Q30354773-7CE1880D-D4D9-4901-AEA5-91DFCA0BECAEQ30542342-C5384AAB-6EDE-4189-ABC3-201C01433D27Q33653871-D70F39E6-C04D-43E1-B840-646D5D4F972FQ34444545-B9224844-3080-40C8-8D09-9EC1EF3AEFB4Q34543035-0A6C7DEC-1EF7-407A-95A8-CAB8021B3FEAQ34583341-4E0946C5-AE89-4990-9E67-5CFD79AB2502Q34718324-5B27B6E2-1517-4519-87C0-F95AEFBC2275Q35014461-C499CB8F-4E95-4001-BF62-E5343D48DAB7Q35459442-DFE0D405-C177-4AC4-B598-69416A7A69AAQ35874173-F3799F1A-78FD-451C-ACDC-7FCA76E0ADEDQ36597980-C6950480-8BAE-45E3-8DAF-F777BC7CF365Q36638881-9C0938CA-C0A0-4F56-934F-4745170839DAQ36782795-8D4B559F-F298-489A-8A28-CFD33FF621E8Q37505169-EFA40EAD-7F84-4ED7-B0C1-AC852299A207Q37820677-46D88B63-02C8-45E0-AAA2-5EB651F5BFFDQ37890782-712E4243-BE9D-4CAB-A648-E9C1E78C5EFEQ37890785-8EC2DDE9-35A0-47F7-9CCB-101C1D7A35DBQ38021678-F75D9030-A7C7-4F43-8F13-B800632E54A7Q38074481-74877D1C-9E17-49D8-8BD3-D212EA97B01CQ38318796-D7E4D004-6DE6-491F-9DC3-2CD8E66051F9Q39462093-8F360D44-BAC2-4D30-B4E0-EC02F3755834Q41853325-020478F7-CF15-4728-891F-C7AC0844EB06Q42555363-C25C42A8-DB66-4DEB-A514-A5956C580D9CQ44091236-2A6B966C-9084-4F5F-87D0-7E02618F42DCQ44798297-357E4D1B-C416-4F32-A74F-991010F7777CQ46672619-73944EFA-9066-4B53-AF93-07DCD90B76DCQ48111429-AFA33D47-13B4-4B55-AE9F-DE2814C3C222Q48522734-EA6AE418-DF3D-455B-B93B-E366709F4AB9Q51739065-EFC62DDE-42F1-4E72-B55A-D154FC3523C0Q53827419-1A1BA014-0AFB-4822-AA13-2A6C840202A9Q55262528-1F5AC129-98E5-4977-8353-97B44D7C3450Q55288083-92C38AB8-C0EA-4023-BE4E-73EAB2B0315F
P2860
Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoglycemia unawareness is as ...... vidence from a clinical audit.
@en
Hypoglycemia unawareness is as ...... vidence from a clinical audit.
@nl
type
label
Hypoglycemia unawareness is as ...... vidence from a clinical audit.
@en
Hypoglycemia unawareness is as ...... vidence from a clinical audit.
@nl
prefLabel
Hypoglycemia unawareness is as ...... vidence from a clinical audit.
@en
Hypoglycemia unawareness is as ...... vidence from a clinical audit.
@nl
P2093
P2860
P921
P356
P1433
P1476
Hypoglycemia unawareness is as ...... evidence from a clinical audit
@en
P2093
Andrew Pernet
Charlotte B Smith
David Hopkins
Stephanie A Amiel
P2860
P304
P356
10.2337/DC08-2259
P407
P577
2009-04-23T00:00:00Z